List view / Grid view
Researchers have developed a radioactive ‘tracer’ molecule to detect myeloid-derived suppressor cells’ accumulating in the lung in preparation for the arrival of breast cancer cells...
A leading gene and cell therapy group has announced a collaboration focusing on gene and cell therapy manufacturing..
A research team have studied how alterations in a tumour depend on each other and how these dependencies determine cancer evolution...
Scientists have described a new type of test that can detect genetic mutations in minute amounts of DNA...
11 August 2017 | By DiscoverX
In this webinar, DiscoverX Corporation discuss three negative allosteric modulators of metabotropic glutamate receptors, developed by Pfizer, which recently failed in preclinical development due to delayed type IV skin hypersensitivity observed in non-human primates...
A research team have discovered that in the Cancer Genome Atlas database the gene expression in reference samples differs from normal tissue, depending on where in the kidney the samples happen to have been taken from...
Researchers have discovered a trove of neuronal subtypes and gene regulators, using a new method they developed called snmC-seq...
The National Institutes of Health is awarding $18.9 million towards research that aims to accelerate the use of genome sequencing in clinical care...
Scientists have made progress in the development of products that improve mitochondrial function...
A new gene therapy that targets the heart and requires only one treatment session has been found safe for patients with coronary artery disease...
Researchers have discovered a new biomarker associated with a rare metabolic disorder may facilitate better diagnosis and identification of new drugs...
Researchers have used CRISPR to stop the expression of individual genes in cancer cells, by knocking out every known protein-encoding gene in the human genome...
Scientists have created a new way of screening compounds that is more sensitive than existing methods, opening up the possibility of finding new drugs...
Rheumatoid arthritis (RA) is joint-related, immune-based inflammatory disarray that affects almost 1% of the world’s population. The most evidenced pathogenesis is T-cell activation, which leads to clusters of differentiation (CD) in the T-cells and concurrently increases various inflammatory biomarkers.
The screening of drug targets against compound libraries is now a mature and validated approach to identifying the chemical starting points of drugs...
